Critical Success Factors in Biomedical Research and Pharmaceutical Innovation - gebunden oder broschiert
ISBN: 9780792335634
[ED: Hardcover], [PU: Springer Netherlands], Is talent the only key to scientific success? In fact, the answer is: No'. Management and organisation do make a real, significant difference … Mehr…
booklooker.de buecher.de GmbH & Co. KG Versandkosten:Versandkostenfrei, Versand nach Deutschland. (EUR 0.00) Details... |
Critical Success Factors in Biomedical Research and Pharmaceutical Innovation - gebunden oder broschiert
ISBN: 9780792335634
Is talent the only key to scientific success? In fact, the answer is: `No'. Management and organisation do make a real, significant difference between success and failure in science. This… Mehr…
Springer.com new in stock. Versandkosten:zzgl. Versandkosten. (EUR 0.00) Details... |
Critical Success Factors in Biomedical Research and Pharmaceutical Innovation The joint impact of management control and contingencies on performance and effectiveness in research laboratories in medical faculties, health research institutes and innovative pharmaceutical companies - gebunden oder broschiert
1995, ISBN: 0792335635
1995 Gebundene Ausgabe Betriebswirtschaft - Betriebswirtschaftslehre, Biologie / Allgemeines, Einführung, Lexikon, Chemie / Lebensmittelchemie, Gesundheitswesen, Betriebswirtschaft und … Mehr…
Achtung-Buecher.de MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien Versandkosten:No shipping costs within Germany. (EUR 0.00) Details... |
Critical Success Factors in Biomedical Research and Pharmaceutical Innovation: The joint impact of management control and contingencies on performance ... and innovative pharmaceutical companies - gebunden oder broschiert
1995, ISBN: 9780792335634
Springer, 1995. Hardcover. Very Good. An ex-library book that is very clean. Interior is clean and bright. Text has No Markings, No Underlining, No Highlighting., Springer, 1995, 3
Biblio.co.uk |
Critical Success Factors in Biomedical Research and Pharmaceutical Innovation - gebunden oder broschiert
1995, ISBN: 9780792335634
The joint impact of management control and contingencies on performance and effectiveness in research laboratories in medical faculties, health research institutes and innovative pharmace… Mehr…
lehmanns.de Versandkosten:Versand in 10-14 Tagen. (EUR 0.00) Details... |
Critical Success Factors in Biomedical Research and Pharmaceutical Innovation - gebunden oder broschiert
ISBN: 9780792335634
[ED: Hardcover], [PU: Springer Netherlands], Is talent the only key to scientific success? In fact, the answer is: No'. Management and organisation do make a real, significant difference … Mehr…
S.W. Omta:
Critical Success Factors in Biomedical Research and Pharmaceutical Innovation - gebunden oder broschiertISBN: 9780792335634
Is talent the only key to scientific success? In fact, the answer is: `No'. Management and organisation do make a real, significant difference between success and failure in science. This… Mehr…
Critical Success Factors in Biomedical Research and Pharmaceutical Innovation The joint impact of management control and contingencies on performance and effectiveness in research laboratories in medical faculties, health research institutes and innovative pharmaceutical companies - gebunden oder broschiert
1995
ISBN: 0792335635
1995 Gebundene Ausgabe Betriebswirtschaft - Betriebswirtschaftslehre, Biologie / Allgemeines, Einführung, Lexikon, Chemie / Lebensmittelchemie, Gesundheitswesen, Betriebswirtschaft und … Mehr…
Critical Success Factors in Biomedical Research and Pharmaceutical Innovation: The joint impact of management control and contingencies on performance ... and innovative pharmaceutical companies - gebunden oder broschiert
1995, ISBN: 9780792335634
Springer, 1995. Hardcover. Very Good. An ex-library book that is very clean. Interior is clean and bright. Text has No Markings, No Underlining, No Highlighting., Springer, 1995, 3
Critical Success Factors in Biomedical Research and Pharmaceutical Innovation - gebunden oder broschiert
1995, ISBN: 9780792335634
The joint impact of management control and contingencies on performance and effectiveness in research laboratories in medical faculties, health research institutes and innovative pharmace… Mehr…
Bibliographische Daten des bestpassenden Buches
Autor: | |
Titel: | |
ISBN-Nummer: |
Detailangaben zum Buch - Critical Success Factors in Biomedical Research and Pharmaceutical Innovation
EAN (ISBN-13): 9780792335634
ISBN (ISBN-10): 0792335635
Gebundene Ausgabe
Erscheinungsjahr: 2007
Herausgeber: Springer
312 Seiten
Gewicht: 0,631 kg
Sprache: eng/Englisch
Buch in der Datenbank seit 2007-11-06T16:02:36+01:00 (Zurich)
Detailseite zuletzt geändert am 2023-08-02T11:52:17+02:00 (Zurich)
ISBN/EAN: 0792335635
ISBN - alternative Schreibweisen:
0-7923-3563-5, 978-0-7923-3563-4
Alternative Schreibweisen und verwandte Suchbegriffe:
Titel des Buches: performance management, success joints, research through performance, the management innovation, research and innovation
Daten vom Verlag:
Autor/in: S.W. Omta
Titel: Critical Success Factors in Biomedical Research and Pharmaceutical Innovation - The joint impact of management control and contingencies on performance and effectiveness in research laboratories in medical faculties, health research institutes and innovative pharmaceutical companies
Verlag: Springer; Springer Netherland
294 Seiten
Erscheinungsjahr: 1995-05-31
Dordrecht; NL
Gewicht: 1,360 kg
Sprache: Englisch
160,49 € (DE)
164,99 € (AT)
177,00 CHF (CH)
POD
XII, 294 p.
BB; Life Sciences, general; Hardcover, Softcover / Biologie; Biowissenschaften, allgemein; Verstehen; biotechnology; distribution; medicine; methodology; organization; Medicine/Public Health, general; Chemistry/Food Science, general; Business and Management, general; Life Sciences; Health Sciences; Chemistry; Business and Management; Medizin, allgemein; Chemie; Betriebswirtschaft und Management; BC; EA
Section 1 Theory.- 1 Research methodology and study domain.- 1.1 The methodology of the study of management and organization.- 1.1.1 The trajectories of theory construction and theory application.- 1.1.2 The TC/TA matrix.- 1.2 Research questions and main hypothesis.- 1.3 Overview of previous studies.- 1.4 Classification of research and development.- 1.5 Industrial innovation.- 1.6 Research and development in the Netherlands.- 1.7 Biomedical research and pharmaceutical innovation.- 1.7.1 Universities.- 1.7.2 Institutes.- 1.7.3 Companies.- 1.8 Concluding remarks.- 2 Structure, behaviour and control.- 2.1 Description of systems.- 2.1.1 Systems and their environment.- 2.1.2 Tight versus loose coupling.- 2.2 Contingencies.- 2.3 Mintzberg’s typology of organizations.- 2.4 The systems theory of control.- 2.4.1 The requirements for effective control.- 2.4.2 Feedback and feedforward control.- 2.5 Universities and institutes.- 2.5.1 Mintzberg’s typology.- 2.5.2 Environmental and organizational constraints.- 2.5.3 Management control.- 2.6 Companies.- 2.6.1 Mintzberg’s typology.- 2.6.2 Environmental and organizational constraints.- 2.6.3 Management control.- 2.7 Concluding remarks.- 3 Structure, behaviour and control in research units.- 3.1 Organizational learning.- 3.2 Research as a value adding learning loop.- 3.2.1 The empirical cycle.- 3.2.2 Management control in the different phases of the empirical cycle.- 3.2.3 The learning loop as a model for organizational change.- 3.2.4 Industrial innovation as a system of value adding learning loops.- 3.3 The double unity cell.- 3.3.1 Universities and institutes.- 3.3.2 Companies.- 3.4 Concluding remarks.- Section 2 Design.- 4 Theory construction.- 4.1 The structure of theory.- 4.2 Theoretical constructs and hypotheses.- 4.3 The defined and empirical concepts.- 4.3.1 Management control.- 4.3.2 Contingencies.- 4.3.3 Performance and effectiveness.- 4.4 Check on completeness.- 4.5 Concluding remarks.- 5 Hypotheses.- 5.1 Management control.- 5.1.1 The objectives and goals.- 5.1.2 Profit versus not-for profit.- 5.1.3 Environmental and task uncertainty.- 5.2 The contingencies.- 5.2.1 Size, economies of scale and threshold level.- 5.2.2 Project size, programmatic homogeneity.- 5.2.3 Time-allocation, research versus clinical practice.- 5.2.4 Age, the life cycle concept.- 5.2.5 Power, internal versus external orientation.- 5.3 Different cross-sections in industry.- 5.3.1 Radical versus incremental orientation.- 5.3.2 Pure play pharmaceuticals versus conglomerates.- 5.3.3 Anglo-American versus continental European companies.- 5.4 Concluding remarks.- 6 Methods of data collection and study methodology.- 6.1 Instruments of data collection.- 6.1.1 Structured interviews and research questionnaires.- 6.1.2 Operational measures for performance and effectiveness.- 6.2 Reliability of instruments.- 6.3 Methods of data analysis.- 6.4 Study population.- 6.4.1 Representativeness of the study sample.- 6.4.2 Approach of study population.- 6.5 Concluding remarks.- Section 3 Results.- 7 Data collection.- 7.1 Response rate.- 7.2 Analysis of non-response.- 7.3 Representativeness.- 7.3.1 Performance and Effectiveness.- 7.3.2 Respondents.- 7.3.3 Unit head versus senior scientific staff.- 7.4 Reliability of instruments.- 7.4.1 The contingencies, and performance and effectiveness.- 7.4.2 Management control.- 7.5 Concluding remarks.- 8 Universities and institutes.- 8.1 Contingencies.- 8.1.1 Staffing structure and age distribution.- 8.1.2 Staffing structure and size.- 8.2 Management control.- 8.3 Performance and effectiveness.- 8.3.1 Size and research performance.- 8.3.2 Annual growth rate.- 8.4 Bivariate associations.- 8.5 Multivariate associations.- 8.6 Organizational level.- 8.7 Concluding remarks.- 9 Companies.- 9.1 Size, performance and effectiveness.- 9.2 Management control.- 9.2.1 Bivariate associations.- 9.2.2 Multivariate associations.- 9.3 Different cross-sections of the study sample.- 9.4 Concluding remarks.- Section 4 Discussion and Conclusions.- 10 Universities and institutes.- 10.1 High and low performers.- 10.2 Organizational level.- 10.3 Differences between universities and institutes.- 10.3.1 Citation score.- 10.4 Economies of scale, threshold level and programme homogeneity.- 10.5 Research and clinical practice.- 10.6 The life cycle concept and age distribution.- 10.7 Internal and external orientation.- 10.8 Customer orientation.- 10.9 Concluding remarks.- 11 Industrial pharmaceutical innovation.- 11.1 High and low performers.- 11.2 Economies of scale.- 11.3 Threshold level.- 11.4 Discovery versus development.- 11.5 Radical versus incremental orientation.- 11.6 Pure play pharmaceuticals and conglomerates.- 11.7 Anglo-American and continental European companies.- 11.8 Concluding remarks.- 12 General conclusions.- 12.1 The research questions.- 12.1.1 High and low performers.- 12.1.2 Comparison of the strata.- 12.2 Study evaluation.- 12.2.1 Strengths and weaknesses of the study design.- 12.2.2 Theory modification.- 12.2.3 Suggestions for further research.- 12.2.4 Theory application.- 12.3 Concluding remarks.- References.- Appendices (A to J).- A Research Questionnaires.- B General questions about R&D management.- C Operationalizations.- D Factor structures.- E Comparison of research units in universities and institutes.- F Spearman rank correlations in universities and institutes.- G Qualitative comparison of universities and institutes.- H Different cross-sections of the industrial study sample.- I Base-line description of the industrial study sample.Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Neuestes ähnliches Buch:
9789401101011 Critical Success Factors in Biomedical Research and Pharmaceutical Innovation (S.W. Omta)
- 9789401101011 Critical Success Factors in Biomedical Research and Pharmaceutical Innovation (S.W. Omta)
- 9789401040488 Critical Success Factors in Biomedical Research and Pharmaceutical Innovation: The joint impact of management control and contingencies on performance and effectiveness in research laboratories in medical faculties, health research institutes and innovati (S.W. Omta)
< zum Archiv...